Advocacy intelligence hub — real-time data for patient organizations
Ethyol: FDA approved
To reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Ethyol
Medimmune Oncology, Inc.
Hussein A Tawbi, MD
University of Pittsburgh Cancer Institute (UPCI)
📍 HOUSTON, TX
Marybeth Hughes, MD, MD
NCI - Surgery Branch
📍 NORFOLK, VA
jean-charles nault, Pr
Federation Francophone de Cancerologie Digestive
Jennifer Johnson, MD, PhD
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Vivek Subbiah, MD, MD
M.D. Anderson Cancer Center
📍 STANFORD, CA
Raymond Bergan, MD, MD
OHSU Knight Cancer Institute
📍 CHICAGO, IL
View all Primary hepatic neuroendocrine carcinoma specialists →